References
- Wise R. Use of antibiotics: cephalosporins. Br. Med. J. 1978; 2: 40–41
- Thompson R. L. The cephalosporins. Mayo Clin. Proc. 1977; 52: 625–630
- Abraham E. P. A glimpse of the early history of the cephalosporins. Rev. Infect. Dis. 1979; 1: 99–105
- Leading Article. Cephalosporins compared. Lancet 1978; i: 863
- Washington J. A., II. Differences between cephalothin and newer parenterally absorbed cephalosporins in vitro: a justification for separate discs. J. Infect. Dis. 1978; 137: S32–37
- Cowan S. T. Cowan and Steel's Manual for the Identification of Medical Bacteria, 2nd ed. Cambridge University Press, London 1974
- Washington J. A., II, Warren E., Dolan C. T., Karlson A. G. Antimicrobial susceptibility tests of bacteria. Laboratory Procedures in Clinical Microbiology, J. A. Washington, II. Little, Brown and Company, Boston 1974; 286–302
- Eickhoff T. C., Ehret J. M. In vitro comparison of cefoxitin, cephamandole, cephalexin and cephalothin. Antimicrob. Agents Chemother. 1976; 9: 994–999
- Barry A. L., Thornsberry C., Jones R. N., et al. Cefuroxime, an in vitro comparison with six other cephalosporins. Proc. R. Soc. Med 1977; 70(Supplement 9)63–70
- Neu H. C., Fu K. P. Cefuroxime, a beta-lactamase resistant cephalosporin with a broad spectrum of gram-positive and negative activity. Antimicrob. Agents Chemother. 1978; 13: 657–664
- Fu K. P., Neu H. C. A comparative study of the activity of cephamandole and other cephalosporins and analysis of the beta-lactamase stability and synergy of cephamandole with aminoglycosides. J. Infect. Dis. 1978; 137: S38–48
- Neu H. C, Fu K. P., Aswapokee N., et al. Comparative activity and beta-lactamase stability of cefoperazone, a piperazine cephalosporin. Antimicrob. Agents Chemother. 1979; 16: 150–157
- Van Laduyt H. W., Pyckavet M. In vitro activity of cefotaxime against cephalothin-resistant clinical isolates. Antimicrob. Agents Chemother. 1979; 16: 109–111
- Bint A. J., Bullock D. W., Speller D. C. E., et al. Cefuroxime therapy for urinary tract infections caused by a multi-resistant, epidemic Klebsiella aerogenes. J. Antimicrob. Chemother. 1979; 5: 189–193
- Jones R. N., Fuchs P. C, Gavan T. L., et al. Cefuroxime, a new parenteral cephalosporin: collaborative in vitro susceptibility comparison with cephalothin against 5, 887 clinical bacterial isolates. Antimicrob. Agents Chemother. 1977; 12: 47–50
- Brogden R. N., Heal R. C, Speight T. M., Avery G. S. Cefoxitin: a review of its antibacterial activity, pharmacological properties and therapeutic use. Drugs 1979; 17: 1–37
- Vuye A., Puck F., van Landuyt H. W. Comparative activity of two newer cephalosporins, cefoxitin, and cephalothin against selected Enterobacteriaceae and correlation with enzymatic resistance mechanisms. J. Antimicrob. Chemother. 1979; 5: 293–300
- Goto S. The in vitro and in vivo antibacterial activity of cefuroxime. Proc. R. Soc. Med 1977; 70(Supplement 9)56–62
- Stapley E. O., Birnbaum J., Miller A. K., et al. Cefoxitin and cephamycins: microbiological studies. Rev. Infect. Dis. 1979; 1: 73–87